581 related articles for article (PubMed ID: 25484040)
1. Rapid identification of an antibody DNA construct rearrangement sequence variant by mass spectrometry.
Scott RA; Rogers R; Balland A; Brady LJ
MAbs; 2014; 6(6):1453-63. PubMed ID: 25484040
[TBL] [Abstract][Full Text] [Related]
2. Characterization of glycation in an IgG1 by capillary electrophoresis sodium dodecyl sulfate and mass spectrometry.
Kaschak T; Boyd D; Yan B
Anal Biochem; 2011 Oct; 417(2):256-63. PubMed ID: 21756870
[TBL] [Abstract][Full Text] [Related]
3. Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibody.
Ren D; Zhang J; Pritchett R; Liu H; Kyauk J; Luo J; Amanullah A
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2877-84. PubMed ID: 21900054
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a unique IgG1 mAb CEX profile by limited Lys-C proteolysis/CEX separation coupled with mass spectrometry and structural analysis.
Kim J; Jones L; Taylor L; Kannan G; Jackson F; Lau H; Latypov RF; Bailey B
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(22):1973-81. PubMed ID: 20554483
[TBL] [Abstract][Full Text] [Related]
5. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
[TBL] [Abstract][Full Text] [Related]
6. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.
Chng J; Wang T; Nian R; Lau A; Hoi KM; Ho SC; Gagnon P; Bi X; Yang Y
MAbs; 2015; 7(2):403-12. PubMed ID: 25621616
[TBL] [Abstract][Full Text] [Related]
7. Analysis of monoclonal antibody product heterogeneity resulting from alternate cleavage sites of signal peptide.
Kotia RB; Raghani AR
Anal Biochem; 2010 Apr; 399(2):190-5. PubMed ID: 20074542
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
[TBL] [Abstract][Full Text] [Related]
9. Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1.
Zhang T; Huang Y; Chamberlain S; Romeo T; Zhu-Shimoni J; Hewitt D; Zhu M; Katta V; Mauger B; Kao YH
MAbs; 2012; 4(6):694-700. PubMed ID: 23018810
[TBL] [Abstract][Full Text] [Related]
10. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry.
Wang D; Wynne C; Gu F; Becker C; Zhao J; Mueller HM; Li H; Shameem M; Liu YH
Anal Chem; 2015 Jan; 87(2):914-21. PubMed ID: 25513708
[TBL] [Abstract][Full Text] [Related]
11. Characterization and identification of alanine to serine sequence variants in an IgG4 monoclonal antibody produced in mammalian cell lines.
Fu J; Bongers J; Tao L; Huang D; Ludwig R; Huang Y; Qian Y; Basch J; Goldstein J; Krishnan R; You L; Li ZJ; Russell RJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():1-8. PubMed ID: 23122394
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of an IgG sequence variant with an 11 kDa heavy chain C-terminal extension using a combination of mass spectrometry and high-throughput sequencing analysis.
Harris C; Xu W; Grassi L; Wang C; Markle A; Hardman C; Stevens R; Miro-Quesada G; Hatton D; Wang J
MAbs; 2019; 11(8):1452-1463. PubMed ID: 31570042
[TBL] [Abstract][Full Text] [Related]
13. Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cells.
Spahr CS; Daris ME; Graham KC; Soriano BD; Stevens JL; Shi SD
MAbs; 2018; 10(8):1291-1300. PubMed ID: 30148415
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a -1 reading frameshift in the heavy chain constant region of an IgG1 recombinant monoclonal antibody produced in CHO cells.
Lian Z; Wu Q; Wang T
MAbs; 2016; 8(2):358-70. PubMed ID: 26652198
[TBL] [Abstract][Full Text] [Related]
15. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
16. Efficient mAb production in CHO cells with optimized signal peptide, codon, and UTR.
You M; Yang Y; Zhong C; Chen F; Wang X; Jia T; Chen Y; Zhou B; Mi Q; Zhao Q; An Z; Luo W; Xia N
Appl Microbiol Biotechnol; 2018 Jul; 102(14):5953-5964. PubMed ID: 29740673
[TBL] [Abstract][Full Text] [Related]
17. Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain.
Johnson KA; Paisley-Flango K; Tangarone BS; Porter TJ; Rouse JC
Anal Biochem; 2007 Jan; 360(1):75-83. PubMed ID: 17113563
[TBL] [Abstract][Full Text] [Related]
18. O-fucosylation of an antibody light chain: characterization of a modification occurring on an IgG1 molecule.
Valliere-Douglass JF; Brady LJ; Farnsworth C; Pace D; Balland A; Wallace A; Wang W; Treuheit MJ; Yan B
Glycobiology; 2009 Feb; 19(2):144-52. PubMed ID: 18952827
[TBL] [Abstract][Full Text] [Related]
19. Characterization of monoclonal antibody size variants containing extra light chains.
Lu C; Liu D; Liu H; Motchnik P
MAbs; 2013; 5(1):102-13. PubMed ID: 23255003
[TBL] [Abstract][Full Text] [Related]
20. O-linked glucosylation of a therapeutic recombinant humanised monoclonal antibody produced in CHO cells.
Tanaka M; Koga A; Kobe A; Sekimori Y; Aso Y; Terada K
Eur J Pharm Biopharm; 2013 Feb; 83(2):123-30. PubMed ID: 23183444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
